logo
Share SHARE
FONT-SIZE Plus   Neg

American Axle Profit Soars On Tax Gains - Update

American Axle & Manufacturing Holdings Inc. (AXL) Friday reported a surge in fourth-quarter profit, helped mostly by one-time tax gains. Revenues for the quarter increased over 21 percent from last year and topped Street estimates, but were offset by higher costs.

American Axle makes driveline and drivetrain systems, and chassis modules for the automotive industry.

The Detroit, Michigan-based company reported fourth-quarter net income of $320 million or $4.21 per share, compared with $31 million or $0.41 per share last year.

On average, 13 analysts polled by Thomson Reuters expected earnings of $0.07 per share for the quarter. Analysts' estimates typically exclude special items.

Results for the reporting quarter included a gain of $337.5 million related to the reversal of valuation allowance against net federal deferred tax assets.

Sale for the quarter totaled $736.7 million, compared with $605.6 million last year. Analysts expected revenues of $731.11 million.

Non-GM sales grew 16.6 percent from the prior year. The company's content-per-vehicle during the quarter was $1,514, compared with $1,498 a year ago.

Cost of sales for the quarter escalated to $653 million from $500 million a year ago, and selling and general overheads increased to $65 million from $57 million, essentially impacting margins.

American Axle is trading at $12.18, up 2.78%, on a volume of 2.2 million shares on the NYSE..

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
The holiday throng seeking to take a flight out to their preferred destinations at the at New York's Kennedy International Airport ahead of the Memorial Day holiday were in for a rude shock. Technology played a spoilsport, as a computer system broke down Sunday evening at a terminal, causing flight delays and cancellations that resulted in manual check-in process for thousands of holiday passeng The month of May saw the FDA greenlight 5 new drugs, including 1 new molecular entity, and surprisingly turn down 1 drug candidate, whose approval was considered a no-brainer by some experts. Lab equipment maker Thermo Fisher Scientific Inc. has agreed to acquire electron microscope maker FEI Co. for about $4.2 billion in cash, the two companies said Friday. Thermo Fisher noted that FEI's electron microscopy platform will complement its own mass spectrometry systems to accelerate advancements in structural biology.
comments powered by Disqus
Follow RTT